Regarding patients with diabetes not on dialysis, other studies have shown increased sclerostin in comparison to the non-diabetic population [19–21], and this may explain, at least in part, the mechanisms underlying bone fragility in diabetics. The gene discussed is SOST; the disease is diabetes mellitus.